Earnings Call · Q2 FY2022·2022-08-06

Q2 22EPS +13.98%·Rev n/aQ1 22EPS -17.65%·Rev n/aQ4 21EPS 0.00%·Rev n/aQ3 21EPS +14.14%·Rev n/a⚠ consensus missing

BIODESIX INC BDSX

Chris Brinzey — Investor Relations or Communications

Scott Hutton — Chief Executive Officer

Robin Harper Cowie — Chief Financial Officer

+4.7%1d on move date+4.8% vs SPY3d+1.1%5d−4.3%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BDSX calls or request research access.

More BDSX calls Browse calls Request research access